https://orcid.org/0000-0002-4748-3818
References
- Graber EM, Dover JS, Arndt KA. Two cases of herpes zoster appearing after botulinum toxin type a injections. J Clin Aesthet Dermatol. 2011;4(10):49–51.
- Zhuang J, Liu T, Hu J. Herpes zoster after botulinum toxin combined with hyaluronic acid injection. J Craniofac Surg. 2023;34(5):1503–1506. doi:10.1097/SCS.0000000000009359
- Amini-Salehi E, Eslami N, Tamimi A, et al. Unusual herpetic reactivation in a young female following botox injection: a case report study. BMC Infect Dis. 2023;23(1):647. doi:10.1186/s12879-023-08514-3
- Wareham DW, Breuer J, Wareham DW, Breuer J. Herpes zoster. BMJ. 2007;334(7605):1211–1215. doi:10.1136/bmj.39206.571042.AE
- Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis. 1995;172(3):706–712. doi:10.1093/infdis/172.3.706
- Watson CP. Postherpetic neuralgia: the importance of preventing this intractable end-stage disorder. J Infect Dis. 1998;178(Suppl 1):S91–S94. doi:10.1086/514269
- Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12(6):492–499. doi:10.1038/ni.2035
- Whitley RJ. A 70-year-old woman with shingles. JAMA. 2009;302(1):73–80. doi:10.1001/jama.2009.822
- Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage. 1997;13(6):327–331. doi:10.1016/S0885-3924(97)00077-8
- McKendrick MW, McGill JI, Wood MJ. Lack of effect of acyclovir on postherpetic neuralgia. BMJ. 1989;298(6671):431. doi:10.1136/bmj.298.6671.431
- Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000;342(9):635–645. Erratum in: N Engl J Med 2000 Apr 6;342(14):1063. doi:10.1056/NEJM200003023420906
- Kubaisi T, Sharquie K. The impact of COVID-19 infection on botulinum toxin hypersensitivity: case report and literature review. J Pak Assoc Dermatol. 2023;33(4):1762–1766.